Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone

Mol Endocrinol. 1994 May;8(5):545-57. doi: 10.1210/mend.8.5.7520127.

Abstract

Insulin rapidly stimulates tyrosine kinase activity of its receptor resulting in phosphorylation of its cytosolic substrate insulin receptor substrate 1 (IRS-1), which in turn associates with and activates the enzyme phosphatidylinositol 3-kinase (PI 3-kinase). In the present study we have examined these three initial steps in insulin action during the differentiation of 3T3-F442A adipocytes and after treatment with dexamethasone or insulin. The differentiation of 3T3-F442A cells was characterized by a 13-fold increase in insulin receptor protein, a 9-fold increase in IRS-1, and a 10- and 4.5-fold increase in their insulin-stimulated phosphorylation, respectively. The mRNA expression of these two proteins showed a similar 8-fold increase during differentiation. In addition there was a 3.5-fold increase in PI 3-kinase protein [85 kilodalton (kDa) subunit] and a 16-fold increase in IRS-1-associated PI 3-kinase activity between day 0 and day 8 of differentiation. Dexamethasone (1 microM) treatment of differentiated cells induced a further 48% (P < 0.05) increase in insulin receptor level, but the autophosphorylation of the receptor was decreased by 31 +/- 1% (P < 0.02). At the same time there was a decrease by 56 +/- 4% (P < 0.005) in IRS-1 protein and by 31 +/- 1% (P < 0.001) in IRS-1 phosphorylation. The expression of insulin receptor mRNA was unchanged, but the expression of IRS-1 mRNA was decreased by approximately 75% after dexamethasone. By contrast, dexamethasone induced a 69% increase in the level of PI 3-kinase as determined by immunoblotting. The combined effect of decreased IRS-1 phosphorylation and increased PI 3-kinase protein was a minimal change (15% decrease) in the association/activation between IRS-1 and PI 3-kinase. Chronic treatment with 100 nM insulin induced a time- and dose-dependent decrease in insulin receptor and IRS-1 protein levels reaching a nadir of 34 +/- 5% (P < 0.005) and 39 +/- 5% (P < 0.01) of control levels after 24 h, respectively. There was an even more marked decrease in the phosphorylation level of these proteins. Chronic insulin treatment also produced a 30% decrease in PI 3-kinase protein levels and a approximately 50% decrease in the association/activation between IRS-1/PI 3-kinase. The expression of insulin receptor and IRS-1 mRNA was unchanged during chronic insulin treatment.(ABSTRACT TRUNCATED AT 400 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3T3 Cells
  • Adipocytes / cytology
  • Adipocytes / drug effects
  • Adipocytes / metabolism*
  • Amino Acid Sequence
  • Animals
  • Antibodies
  • Base Sequence
  • Cell Differentiation
  • DNA Primers
  • Dexamethasone / pharmacology*
  • Enzyme Activation
  • Gene Expression
  • Immunoblotting
  • Insulin / pharmacology*
  • Insulin Receptor Substrate Proteins
  • Kinetics
  • Mice
  • Molecular Sequence Data
  • Oligopeptides / chemical synthesis
  • Oligopeptides / immunology
  • Phosphatidylinositol 3-Kinases
  • Phosphoproteins / biosynthesis*
  • Phosphorylation
  • Phosphotransferases (Alcohol Group Acceptor) / biosynthesis*
  • Phosphotyrosine
  • Polymerase Chain Reaction
  • Protein Tyrosine Phosphatases / metabolism
  • RNA, Messenger / biosynthesis
  • Receptor, Insulin / biosynthesis*
  • Time Factors
  • Tyrosine / analogs & derivatives
  • Tyrosine / analysis

Substances

  • Antibodies
  • DNA Primers
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, mouse
  • Oligopeptides
  • Phosphoproteins
  • RNA, Messenger
  • Phosphotyrosine
  • Tyrosine
  • Dexamethasone
  • Phosphatidylinositol 3-Kinases
  • Phosphotransferases (Alcohol Group Acceptor)
  • Receptor, Insulin
  • Protein Tyrosine Phosphatases